Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,424Revenue (TTM) $M40.5Net Margin (%)-1,301.2Altman Z-Score11.4
Enterprise Value $M6,073EPS (TTM) $-10.0Operating Margin %-1,262.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score34.0Pre-tax Margin (%)-1,297.2Higher ROA y-yN
Price/Book16.110-y EBITDA Growth Rate %--Quick Ratio5.4Cash flow > EarningsY
Price/Sales1575-y EBITDA Growth Rate %-14.5Current Ratio5.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-80.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-120.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M54.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with TSRO

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

TSRO is held by these investors:



TSRO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Huber Martin H. Jr.SVP & Chief Medical Officer 2017-09-22Sell592$118.6-0.03view
Armitage James ODirector 2017-09-18Sell10,000$117.131.22view
English Edward CVP of Finance & Administration 2017-09-06Sell10,862$134.92-12.13view
Oliveira OrlandoSVP & GM, International 2017-09-05Sell71$132.66-10.63view
Bogle Grant C.Sr. VP, Chief Commercial Ofc. 2017-09-01Sell14,167$135-12.18view
English Edward CVP of Finance & Administration 2017-06-06Sell8,500$138.65-14.49view
Huber Martin H. Jr.SVP & Cheif Medical Officer 2017-04-03Sell829$153.02-22.52view
English Edward CV.P. of Finance & Admin. 2017-03-06Sell10,000$178.06-33.42view
PEARSON TIMOTHY RExec. VP, CFO 2017-03-02Sell1,447$177.61-33.25view
Oliveira OrlandoSVP & GM, International 2017-03-02Sell249$177.61-33.25view

Press Releases about TSRO :

Quarterly/Annual Reports about TSRO:

News about TSRO:

Articles On GuruFocus.com
TESARO Receives Positive CHMP Opinion for ZEJULA® Sep 15 2017 
TESARO Summarizes ZEJULA and TSR-042 Data Presented at the 2017 ESMO Annual Meeting Sep 11 2017 
TESARO Announces Nine Data Presentations at the 2017 European Society for Medical Oncology (ESMO) A Aug 25 2017 
TESARO Announces Participation at Four Investor Conferences Aug 23 2017 
Vanguard Health Care Fund Adds to Multiple Positions Aug 01 2017 
TESARO and Takeda Enter Into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Jul 27 2017 
TESARO to Announce Second-Quarter 2017 Financial Results on August 8, 2017 Jul 25 2017 
TESARO Announces Participation at Goldman Sachs 38th Annual Global Healthcare Conference Jun 07 2017 
TESARO Provides Business and Pipeline Update at ASCO Investor Briefing Jun 03 2017 
Tesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO) May 25 2017 

More From Other Websites
No related articles found.

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}